Found 97 hits with Last Name = 'robson' and Initial = 'a' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246925
(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-3-methyl...)Show SMILES Cc1cc(ccc1CNC(=O)Nc1c(F)cccc1F)C(=O)N1CCCCc2ccccc12 Show InChI InChI=1S/C26H25F2N3O2/c1-17-15-19(25(32)31-14-5-4-8-18-7-2-3-11-23(18)31)12-13-20(17)16-29-26(33)30-24-21(27)9-6-10-22(24)28/h2-3,6-7,9-13,15H,4-5,8,14,16H2,1H3,(H2,29,30,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Binding affinity to human vasopressin V2 receptor expressed in HEK293 cells by radioligand binding assay |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Serine/threonine-protein kinase mTOR
(Homo sapiens (Human)) | BDBM25028
(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)Show SMILES CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 Show InChI InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| 580 | -35.6 | n/a | n/a | n/a | n/a | n/a | 7.5 | 25 |
Piramed Pharma
| Assay Description Mammalian target of rapamycin (mTOR) was assayed by monitoring phosphorylation of GFP-4EBP using a homogeneous time-resolved fluorescence resonance e... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246575
(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)Show SMILES CN(C)C(=O)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1CCCCc2ccccc12 |r| Show InChI InChI=1S/C27H34N4O3/c1-19-17-21(25(32)30-15-7-6-10-20-9-4-5-11-23(20)30)13-14-22(19)18-28-27(34)31-16-8-12-24(31)26(33)29(2)3/h4-5,9,11,13-14,17,24H,6-8,10,12,15-16,18H2,1-3H3,(H,28,34)/t24-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Binding affinity to human vasopressin V2 receptor expressed in HEK293 cells by radioligand binding assay |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50246575
(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)Show SMILES CN(C)C(=O)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1CCCCc2ccccc12 |r| Show InChI InChI=1S/C27H34N4O3/c1-19-17-21(25(32)30-15-7-6-10-20-9-4-5-11-23(20)30)13-14-22(19)18-28-27(34)31-16-8-12-24(31)26(33)29(2)3/h4-5,9,11,13-14,17,24H,6-8,10,12,15-16,18H2,1-3H3,(H,28,34)/t24-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Binding affinity to oxytocin receptor (unknown origin) |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50246890
(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]benzoyl)-...)Show SMILES Fc1cccc(F)c1NC(=O)NCc1ccc(cc1)C(=O)N1CCCCc2ccccc12 Show InChI InChI=1S/C25H23F2N3O2/c26-20-8-5-9-21(27)23(20)29-25(32)28-16-17-11-13-19(14-12-17)24(31)30-15-4-3-7-18-6-1-2-10-22(18)30/h1-2,5-6,8-14H,3-4,7,15-16H2,(H2,28,29,32) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Binding affinity to oxytocin receptor (unknown origin) |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50246925
(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-3-methyl...)Show SMILES Cc1cc(ccc1CNC(=O)Nc1c(F)cccc1F)C(=O)N1CCCCc2ccccc12 Show InChI InChI=1S/C26H25F2N3O2/c1-17-15-19(25(32)31-14-5-4-8-18-7-2-3-11-23(18)31)12-13-20(17)16-29-26(33)30-24-21(27)9-6-10-22(24)28/h2-3,6-7,9-13,15H,4-5,8,14,16H2,1H3,(H2,29,30,33) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Binding affinity to oxytocin receptor (unknown origin) |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM25028
(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)Show SMILES CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 Show InChI InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25021
(3-{6-[(dimethylamino)methyl]-4-(morpholin-4-yl)thi...)Show SMILES CN(C)Cc1cc2nc(nc(N3CCOCC3)c2s1)-c1cccc(O)c1 Show InChI InChI=1S/C19H22N4O2S/c1-22(2)12-15-11-16-17(26-15)19(23-6-8-25-9-7-23)21-18(20-16)13-4-3-5-14(24)10-13/h3-5,10-11,24H,6-9,12H2,1-2H3 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [H1047R]
(Homo sapiens (Human)) | BDBM25028
(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)Show SMILES CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 Show InChI InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [E545K]
(Homo sapiens (Human)) | BDBM25028
(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)Show SMILES CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 Show InChI InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) | PDB MMDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25028
(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)Show SMILES CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 Show InChI InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25022
(3-(6-{[(2-methoxyethyl)(methyl)amino]methyl}-4-(mo...)Show SMILES COCCN(C)Cc1cc2nc(nc(N3CCOCC3)c2s1)-c1cccc(O)c1 Show InChI InChI=1S/C21H26N4O3S/c1-24(6-9-27-2)14-17-13-18-19(29-17)21(25-7-10-28-11-8-25)23-20(22-18)15-4-3-5-16(26)12-15/h3-5,12-13,26H,6-11,14H2,1-2H3 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25019
(3-[6-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimid...)Show InChI InChI=1S/C17H17N3O2S/c1-11-9-14-15(23-11)17(20-5-7-22-8-6-20)19-16(18-14)12-3-2-4-13(21)10-12/h2-4,9-10,21H,5-8H2,1H3 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25024
(3-(6-{[4-(2-hydroxyethyl)piperazin-1-yl]methyl}-4-...)Show SMILES OCCN1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc(O)c2)CC1 Show InChI InChI=1S/C23H29N5O3S/c29-11-8-26-4-6-27(7-5-26)16-19-15-20-21(32-19)23(28-9-12-31-13-10-28)25-22(24-20)17-2-1-3-18(30)14-17/h1-3,14-15,29-30H,4-13,16H2 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25018
(3-(4-morpholin-4-ylthieno[3,2-d]pyrimidin-2-yl)phe...)Show InChI InChI=1S/C16H15N3O2S/c20-12-3-1-2-11(10-12)15-17-13-4-9-22-14(13)16(18-15)19-5-7-21-8-6-19/h1-4,9-10,20H,5-8H2 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25023
(3-{6-[(4-methylpiperazin-1-yl)methyl]-4-(morpholin...)Show SMILES CN1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc(O)c2)CC1 Show InChI InChI=1S/C22H27N5O2S/c1-25-5-7-26(8-6-25)15-18-14-19-20(30-18)22(27-9-11-29-12-10-27)24-21(23-19)16-3-2-4-17(28)13-16/h2-4,13-14,28H,5-12,15H2,1H3 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25020
(3-[7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimid...)Show InChI InChI=1S/C17H17N3O2S/c1-11-10-23-15-14(11)18-16(12-3-2-4-13(21)9-12)19-17(15)20-5-7-22-8-6-20/h2-4,9-10,21H,5-8H2,1H3 | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 21 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM25028
(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)Show SMILES CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 Show InChI InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| Purchase
MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 33 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25027
(4-[2-(1H-indazol-4-yl)-6-[(4-methylpiperazin-1-yl)...)Show SMILES CN1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 Show InChI InChI=1S/C23H27N7OS/c1-28-5-7-29(8-6-28)15-16-13-20-21(32-16)23(30-9-11-31-12-10-30)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 44 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM25028
(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)Show SMILES CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 Show InChI InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| MMDB PDB Article PubMed
| n/a | n/a | 75 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25025
(4-[2-(1H-indazol-4-yl)thieno[3,2-d]pyrimidin-4-yl]...)Show InChI InChI=1S/C17H15N5OS/c1-2-11(12-10-18-21-13(12)3-1)16-19-14-4-9-24-15(14)17(20-16)22-5-7-23-8-6-22/h1-4,9-10H,5-8H2,(H,18,21) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 102 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta
(Homo sapiens (Human)) | BDBM25028
(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)Show SMILES CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 Show InChI InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) | NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| Purchase
MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 670 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase regulatory subunit alpha/4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM25026
(4-[2-(1H-indazol-6-yl)thieno[3,2-d]pyrimidin-4-yl]...)Show InChI InChI=1S/C17H15N5OS/c1-2-12-10-18-21-14(12)9-11(1)16-19-13-3-8-24-15(13)17(20-16)22-4-6-23-7-5-22/h1-3,8-10H,4-7H2,(H,18,21) | PDB
UniProtKB/SwissProt
antibodypedia antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.45E+3 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 3-kinase catalytic subunit type 3
(Homo sapiens (Human)) | BDBM25028
(4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpipera...)Show SMILES CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)-c2cccc3[nH]ncc23)CC1 Show InChI InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a | 7.5 | 22 |
Piramed Pharma
| Assay Description Test compounds were added to reaction buffer containing yttrium silicate (Ysi) polylysine SPA beads (Amersham), and the enzyme was added to the assay... |
J Med Chem 51: 5522-32 (2008)
Article DOI: 10.1021/jm800295d BindingDB Entry DOI: 10.7270/Q2222S23 |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246576
(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)Show SMILES CCN(CC)C(=O)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1CCCCc2ccccc12 |r| Show InChI InChI=1S/C29H38N4O3/c1-4-31(5-2)28(35)26-14-10-18-33(26)29(36)30-20-24-16-15-23(19-21(24)3)27(34)32-17-9-8-12-22-11-6-7-13-25(22)32/h6-7,11,13,15-16,19,26H,4-5,8-10,12,14,17-18,20H2,1-3H3,(H,30,36)/t26-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 350 | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report... |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246577
(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)Show SMILES CN(C)C(=O)[C@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1CCCCc2ccccc12 |r| Show InChI InChI=1S/C27H34N4O3/c1-19-17-21(25(32)30-15-7-6-10-20-9-4-5-11-23(20)30)13-14-22(19)18-28-27(34)31-16-8-12-24(31)26(33)29(2)3/h4-5,9,11,13-14,17,24H,6-8,10,12,15-16,18H2,1-3H3,(H,28,34)/t24-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 380 | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report... |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246578
(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)Show SMILES CN(C)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1CCCCc2ccccc12 |r| Show InChI InChI=1S/C27H34N4O2S/c1-19-17-21(25(32)30-15-7-6-10-20-9-4-5-11-23(20)30)13-14-22(19)18-28-27(33)31-16-8-12-24(31)26(34)29(2)3/h4-5,9,11,13-14,17,24H,6-8,10,12,15-16,18H2,1-3H3,(H,28,33)/t24-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 3.20 | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report... |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246596
((4R)-4-Hydroxy-1-(2-methyl-4-(2,3,4,5-tetrahydro-1...)Show SMILES CN(C)C(=O)[C@@H]1C[C@@H](O)CN1C(=O)NCc1ccc(cc1C)C(=O)N1CCCCc2ccccc12 |r| Show InChI InChI=1S/C27H34N4O4/c1-18-14-20(25(33)30-13-7-6-9-19-8-4-5-10-23(19)30)11-12-21(18)16-28-27(35)31-17-22(32)15-24(31)26(34)29(2)3/h4-5,8,10-12,14,22,24,32H,6-7,9,13,15-17H2,1-3H3,(H,28,35)/t22-,24+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.30 | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report... |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246890
(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]benzoyl)-...)Show SMILES Fc1cccc(F)c1NC(=O)NCc1ccc(cc1)C(=O)N1CCCCc2ccccc12 Show InChI InChI=1S/C25H23F2N3O2/c26-20-8-5-9-21(27)23(20)29-25(32)28-16-17-11-13-19(14-12-17)24(31)30-15-4-3-7-18-6-1-2-10-22(18)30/h1-2,5-6,8-14H,3-4,7,15-16H2,(H2,28,29,32) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 47 | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report... |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246922
(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-2-fluoro...)Show SMILES Fc1cc(CNC(=O)Nc2c(F)cccc2F)ccc1C(=O)N1CCCCc2ccccc12 Show InChI InChI=1S/C25H22F3N3O2/c26-19-8-5-9-20(27)23(19)30-25(33)29-15-16-11-12-18(21(28)14-16)24(32)31-13-4-3-7-17-6-1-2-10-22(17)31/h1-2,5-6,8-12,14H,3-4,7,13,15H2,(H2,29,30,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 180 | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report... |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246923
(1-(2-Chloro-4-[3-(2,6-difluorophenyl)ureidomethyl]...)Show SMILES Fc1cccc(F)c1NC(=O)NCc1ccc(C(=O)N2CCCCc3ccccc23)c(Cl)c1 Show InChI InChI=1S/C25H22ClF2N3O2/c26-19-14-16(15-29-25(33)30-23-20(27)8-5-9-21(23)28)11-12-18(19)24(32)31-13-4-3-7-17-6-1-2-10-22(17)31/h1-2,5-6,8-12,14H,3-4,7,13,15H2,(H2,29,30,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 40 | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report... |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246924
(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-2-methox...)Show SMILES COc1cc(CNC(=O)Nc2c(F)cccc2F)ccc1C(=O)N1CCCCc2ccccc12 Show InChI InChI=1S/C26H25F2N3O3/c1-34-23-15-17(16-29-26(33)30-24-20(27)9-6-10-21(24)28)12-13-19(23)25(32)31-14-5-4-8-18-7-2-3-11-22(18)31/h2-3,6-7,9-13,15H,4-5,8,14,16H2,1H3,(H2,29,30,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 110 | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report... |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50246925
(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-3-methyl...)Show SMILES Cc1cc(ccc1CNC(=O)Nc1c(F)cccc1F)C(=O)N1CCCCc2ccccc12 Show InChI InChI=1S/C26H25F2N3O2/c1-17-15-19(25(32)31-14-5-4-8-18-7-2-3-11-23(18)31)12-13-20(17)16-29-26(33)30-24-21(27)9-6-10-22(24)28/h2-3,6-7,9-13,15H,4-5,8,14,16H2,1H3,(H2,29,30,33) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a |
Vantia Ltd
Curated by ChEMBL
| Assay Description Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report... |
J Med Chem 51: 8124-34 (2008)
Article DOI: 10.1021/jm8008162 BindingDB Entry DOI: 10.7270/Q28W3D6V |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152972
((2S,4R)-4-Methoxy-2-(4-methyl-[1,4]diazepane-1-car...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=S)N1CCCN(C)CC1 Show InChI InChI=1S/C29H38ClN5O3S2/c1-32-10-5-11-33(14-13-32)28(39)25-17-22(38-2)19-35(25)29(37)31-18-21-8-7-20(16-23(21)30)27(36)34-12-4-3-6-26-24(34)9-15-40-26/h7-9,15-16,22,25H,3-6,10-14,17-19H2,1-2H3,(H,31,37)/t22-,25+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 430 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152973
((S)-2-(4-Methyl-[1,4]diazepane-1-carbothioyl)-pyrr...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12 Show InChI InChI=1S/C28H36ClN5O2S2/c1-31-11-5-12-32(16-15-31)27(37)24-6-4-14-34(24)28(36)30-19-21-9-8-20(18-22(21)29)26(35)33-13-3-2-7-25-23(33)10-17-38-25/h8-10,17-18,24H,2-7,11-16,19H2,1H3,(H,30,36)/t24-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 810 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152972
((2S,4R)-4-Methoxy-2-(4-methyl-[1,4]diazepane-1-car...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=S)N1CCCN(C)CC1 Show InChI InChI=1S/C29H38ClN5O3S2/c1-32-10-5-11-33(14-13-32)28(39)25-17-22(38-2)19-35(25)29(37)31-18-21-8-7-20(16-23(21)30)27(36)34-12-4-3-6-26-24(34)9-15-40-26/h7-9,15-16,22,25H,3-6,10-14,17-19H2,1-2H3,(H,31,37)/t22-,25+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 230 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152974
((2S)-N-{2-Methyl-4-[(1-methyl-4,10-dihydropyrazolo...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1Cc2cnn(C)c2Nc2ccccc12 Show InChI InChI=1S/C32H40N8O2S/c1-22-18-23(30(41)40-21-25-20-34-37(3)29(25)35-26-8-4-5-9-27(26)40)11-12-24(22)19-33-32(42)39-15-6-10-28(39)31(43)38-14-7-13-36(2)16-17-38/h4-5,8-9,11-12,18,20,28,35H,6-7,10,13-17,19,21H2,1-3H3,(H,33,42)/t28-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 850 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152975
((2S,4R)-4-Methoxy-2-(2-pyridin-2-yl-ethylthiocarba...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=S)NCCc1ccccn1 Show InChI InChI=1S/C30H34ClN5O3S2/c1-39-23-17-26(28(40)33-13-10-22-6-2-4-12-32-22)36(19-23)30(38)34-18-21-9-8-20(16-24(21)31)29(37)35-14-5-3-7-27-25(35)11-15-41-27/h2,4,6,8-9,11-12,15-16,23,26H,3,5,7,10,13-14,17-19H2,1H3,(H,33,40)(H,34,38)/t23-,26+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 200 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152976
((3S,5R)-4-Methoxy-pyrrolidine-1,2-dicarboxylic aci...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)NCCc1ccccn1 Show InChI InChI=1S/C30H34ClN5O4S/c1-40-23-17-26(28(37)33-13-10-22-6-2-4-12-32-22)36(19-23)30(39)34-18-21-9-8-20(16-24(21)31)29(38)35-14-5-3-7-27-25(35)11-15-41-27/h2,4,6,8-9,11-12,15-16,23,26H,3,5,7,10,13-14,17-19H2,1H3,(H,33,37)(H,34,39)/t23-,26+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152977
((3S,5R)-4-Methoxy-2-(4-pyrrolidin-1-yl-piperidine-...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCC(CC1)N1CCCC1 Show InChI InChI=1S/C32H42ClN5O4S/c1-42-25-19-28(31(40)36-15-9-24(10-16-36)35-12-4-5-13-35)38(21-25)32(41)34-20-23-8-7-22(18-26(23)33)30(39)37-14-3-2-6-29-27(37)11-17-43-29/h7-8,11,17-18,24-25,28H,2-6,9-10,12-16,19-21H2,1H3,(H,34,41)/t25-,28+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.10E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152978
((3S,5R)-4-Methoxy-2-(4-methyl-[1,4]diazepane-1-car...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCCN(C)CC1 Show InChI InChI=1S/C29H38ClN5O4S/c1-32-10-5-11-33(14-13-32)28(37)25-17-22(39-2)19-35(25)29(38)31-18-21-8-7-20(16-23(21)30)27(36)34-12-4-3-6-26-24(34)9-15-40-26/h7-9,15-16,22,25H,3-6,10-14,17-19H2,1-2H3,(H,31,38)/t22-,25+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152979
((S)-2-(4-Methyl-[1,4]diazepane-1-carbothioyl)-pyrr...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1CCCCc2sccc12 Show InChI InChI=1S/C29H39N5O2S2/c1-21-19-22(27(35)33-14-4-3-8-26-24(33)11-18-38-26)9-10-23(21)20-30-29(36)34-15-5-7-25(34)28(37)32-13-6-12-31(2)16-17-32/h9-11,18-19,25H,3-8,12-17,20H2,1-2H3,(H,30,36)/t25-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 890 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152980
((3S,5R)-2-([1,4'']Bipiperidinyl-1''-carbonyl)-4-me...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCC(CC1)N1CCCCC1 Show InChI InChI=1S/C33H44ClN5O4S/c1-43-26-20-29(32(41)37-16-10-25(11-17-37)36-13-4-2-5-14-36)39(22-26)33(42)35-21-24-9-8-23(19-27(24)34)31(40)38-15-6-3-7-30-28(38)12-18-44-30/h8-9,12,18-19,25-26,29H,2-7,10-11,13-17,20-22H2,1H3,(H,35,42)/t26-,29+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152981
((2S,4R)-4-Methoxy-2-(4-pyrrolidin-1-yl-piperidine-...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=S)N1CCC(CC1)N1CCCC1 Show InChI InChI=1S/C32H42ClN5O3S2/c1-41-25-19-28(31(42)36-15-9-24(10-16-36)35-12-4-5-13-35)38(21-25)32(40)34-20-23-8-7-22(18-26(23)33)30(39)37-14-3-2-6-29-27(37)11-17-43-29/h7-8,11,17-18,24-25,28H,2-6,9-10,12-16,19-21H2,1H3,(H,34,40)/t25-,28+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 100 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152974
((2S)-N-{2-Methyl-4-[(1-methyl-4,10-dihydropyrazolo...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1Cc2cnn(C)c2Nc2ccccc12 Show InChI InChI=1S/C32H40N8O2S/c1-22-18-23(30(41)40-21-25-20-34-37(3)29(25)35-26-8-4-5-9-27(26)40)11-12-24(22)19-33-32(42)39-15-6-10-28(39)31(43)38-14-7-13-36(2)16-17-38/h4-5,8-9,11-12,18,20,28,35H,6-7,10,13-17,19,21H2,1-3H3,(H,33,42)/t28-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 33 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152973
((S)-2-(4-Methyl-[1,4]diazepane-1-carbothioyl)-pyrr...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12 Show InChI InChI=1S/C28H36ClN5O2S2/c1-31-11-5-12-32(16-15-31)27(37)24-6-4-14-34(24)28(36)30-19-21-9-8-20(18-22(21)29)26(35)33-13-3-2-7-25-23(33)10-17-38-25/h8-10,17-18,24H,2-7,11-16,19H2,1H3,(H,30,36)/t24-/m0/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152977
((3S,5R)-4-Methoxy-2-(4-pyrrolidin-1-yl-piperidine-...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCC(CC1)N1CCCC1 Show InChI InChI=1S/C32H42ClN5O4S/c1-42-25-19-28(31(40)36-15-9-24(10-16-36)35-12-4-5-13-35)38(21-25)32(41)34-20-23-8-7-22(18-26(23)33)30(39)37-14-3-2-6-29-27(37)11-17-43-29/h7-8,11,17-18,24-25,28H,2-6,9-10,12-16,19-21H2,1H3,(H,34,41)/t25-,28+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 2.30E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Vasopressin V2 receptor
(Homo sapiens (Human)) | BDBM50152980
((3S,5R)-2-([1,4'']Bipiperidinyl-1''-carbonyl)-4-me...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)N1CCC(CC1)N1CCCCC1 Show InChI InChI=1S/C33H44ClN5O4S/c1-43-26-20-29(32(41)37-16-10-25(11-17-37)36-13-4-2-5-14-36)39(22-26)33(42)35-21-24-9-8-23(19-27(24)34)31(40)38-15-6-3-7-30-28(38)12-18-44-30/h8-9,12,18-19,25-26,29H,2-7,10-11,13-17,20-22H2,1H3,(H,35,42)/t26-,29+/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Vassopressin V2 receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152979
((S)-2-(4-Methyl-[1,4]diazepane-1-carbothioyl)-pyrr...)Show SMILES CN1CCCN(CC1)C(=S)[C@@H]1CCCN1C(=O)NCc1ccc(cc1C)C(=O)N1CCCCc2sccc12 Show InChI InChI=1S/C29H39N5O2S2/c1-21-19-22(27(35)33-14-4-3-8-26-24(33)11-18-38-26)9-10-23(21)20-30-29(36)34-15-5-7-25(34)28(37)32-13-6-12-31(2)16-17-32/h9-11,18-19,25H,3-8,12-17,20H2,1-2H3,(H,30,36)/t25-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 640 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |
Oxytocin receptor
(Homo sapiens (Human)) | BDBM50152982
((2S,4R)-4-Methoxy-pyrrolidine-1,2-dicarboxylic aci...)Show SMILES CO[C@@H]1C[C@H](N(C1)C(=O)NCc1ccc(cc1Cl)C(=O)N1CCCCc2sccc12)C(=O)NCCN(C)C Show InChI InChI=1S/C27H36ClN5O4S/c1-31(2)12-10-29-25(34)23-15-20(37-3)17-33(23)27(36)30-16-19-8-7-18(14-21(19)28)26(35)32-11-5-4-6-24-22(32)9-13-38-24/h7-9,13-14,20,23H,4-6,10-12,15-17H2,1-3H3,(H,29,34)(H,30,36)/t20-,23+/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | >1.00E+4 | n/a | n/a | n/a | n/a |
Ferring Research Ltd
Curated by ChEMBL
| Assay Description Effective concentration for human Oxytocin receptor |
Bioorg Med Chem Lett 14: 4585-9 (2004)
Article DOI: 10.1016/j.bmcl.2004.04.107 BindingDB Entry DOI: 10.7270/Q2DF6QPR |
More data for this Ligand-Target Pair | |